(Q41612469)

5 October 2017

1 reference

title

Serotonin syndrome. A clinical update (English)

1 reference

5 October 2017

Mills KC

1

1 reference

5 October 2017

publication date

1 October 1997

1 reference

5 October 2017

published in

Critical Care Clinics

1 reference

5 October 2017

volume

13

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

763-783

1 reference

Serotonin syndrome from fluvoxamine and buspirone

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Myoclonus and ocular oscillations induced by L-tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Psychopharmacology of central serotonergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

1 reference

7 January 2021

A toxic reaction from combining fluoxetine and phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Sertraline and isocarboxazid cause a serotonin syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

'Neuroleptic malignant syndrome' without neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Efficacy and adverse effects of moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Nitroglycerin in the treatment of the serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Pathophysiology and management of the serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome in the elderly after antidepressive monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Motor effects of serotonin in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome from trazodone and buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Sertraline-phenelzine drug interaction: a serotonin syndrome reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Fluoxetine and neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Interaction of fluoxetine and pentazocine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome induced by administration of venlafaxine and phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Mirtazapine as treatment for serotonin syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Possible development of the serotonin syndrome in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

An animal behavior model for studying central serotonergic synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Brain stem and spinal cord mediation of a serotonergic behavioral syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

The serotonin syndrome in a patient receiving sertraline after an ankle block

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Sertraline intoxication in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

1 reference

7 January 2021

Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome produced by a combination of fluoxetine and lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

The central nervous system serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Drug-induced hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome induced by fluvoxamine-lithium interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Toxic effects of iproniazid in a patient with angina

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Hyperpyrexia following psychotropic drug overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome produced by paroxetine and low-dose trazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

NMS-Like syndrome with a lithium/doxepin combination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Fluoxetine and the serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Dangerous potentiation of pethidine by iproniazid, and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

A case of MAO inhibitor/MDMA interaction: agony after ecstasy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Central-nervous-system effects of ingestin of L-tryptophan by normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Serotonin syndrome caused by a moclobemide-clomipramine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Perioperative seizures and fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

The serotonin syndrome. Implicated drugs, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Case report of a toxic reaction from a combination of tryptophan and phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

DANGEROUS POTENTIATION OF MEPERIDINE HYDROCHLORIDE BY PARGYLINE HYDROCHLORIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

Severe adverse interaction between pethidine and selegiline

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970368-7

7 January 2021

10.1016/S0749-0704(05)70368-7

Identifiers

DOI

1 reference

5 October 2017

1 reference